Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease

Clin Genet. 2006 Jul;70(1):78-9. doi: 10.1111/j.1399-0004.2006.00636.x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers / cerebrospinal fluid
  • Case-Control Studies
  • Female
  • Humans
  • Huntingtin Protein
  • Huntington Disease / cerebrospinal fluid*
  • Intracellular Signaling Peptides and Proteins / cerebrospinal fluid*
  • Male
  • Mice
  • Mice, Transgenic
  • Middle Aged
  • Nerve Tissue Proteins / genetics
  • Neuropeptides / cerebrospinal fluid*
  • Nuclear Proteins / genetics
  • Orexins
  • Recombinant Proteins / genetics

Substances

  • Biomarkers
  • HCRT protein, human
  • HTT protein, human
  • Huntingtin Protein
  • Intracellular Signaling Peptides and Proteins
  • Nerve Tissue Proteins
  • Neuropeptides
  • Nuclear Proteins
  • Orexins
  • Recombinant Proteins